Log in

NYSE:QGEN - Qiagen Stock Price, Forecast & News

$36.47
+1.38 (+3.93 %)
(As of 02/28/2020 01:35 AM ET)
Today's Range
$35.84
Now: $36.47
$37.60
50-Day Range
$33.17
MA: $35.45
$37.38
52-Week Range
$25.04
Now: $36.47
$43.16
Volume5.12 million shs
Average Volume2.34 million shs
Market Capitalization$8.22 billion
P/E RatioN/A
Dividend YieldN/A
Beta0.92
QIAGEN N.V. provides sample to insight solutions that transform biological materials into molecular insights worldwide. The company offers sample technologies for plasmid deoxyribonucleic acid (DNA) purification, ribonucleic acid purification and stabilization, genomic and viral nucleic acid purification, DNA cleanup after polymerase chain reaction (PCR) and sequencing, target enrichment, and library preparation for sequencing applications; and assay technology solutions. Read More…

Industry, Sector and Symbol

Industry Biological products, except diagnostic
Sub-IndustryN/A
SectorMedical
CUSIPN/A
Phone31-77-355-6600

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.53 billion
Cash Flow$2.80 per share
Book Value$11.25 per share

Profitability

Net Income$-41,460,000.00

Miscellaneous

Employees4,952
Market Cap$8.22 billion
Next Earnings Date5/4/2020 (Estimated)
OptionableOptionable

Receive QGEN News and Ratings via Email

Sign-up to receive the latest news and ratings for QGEN and its competitors with MarketBeat's FREE daily newsletter.


Qiagen (NYSE:QGEN) Frequently Asked Questions

What is Qiagen's stock symbol?

Qiagen trades on the New York Stock Exchange (NYSE) under the ticker symbol "QGEN."

How were Qiagen's earnings last quarter?

Qiagen NV (NYSE:QGEN) announced its earnings results on Tuesday, February, 4th. The company reported $0.48 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.44 by $0.04. The company had revenue of $413.50 million for the quarter, compared to analysts' expectations of $408.28 million. Qiagen had a negative net margin of 2.72% and a positive return on equity of 13.00%. The firm's quarterly revenue was up 2.6% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.40 EPS. View Qiagen's Earnings History.

When is Qiagen's next earnings date?

Qiagen is scheduled to release their next quarterly earnings announcement on Monday, May 4th 2020. View Earnings Estimates for Qiagen.

What guidance has Qiagen issued on next quarter's earnings?

Qiagen issued an update on its FY20 earnings guidance on Tuesday, February, 4th. The company provided EPS guidance of $1.52-1.54 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.51.

What price target have analysts set for QGEN?

20 analysts have issued 1 year price objectives for Qiagen's shares. Their forecasts range from $28.00 to $48.00. On average, they anticipate Qiagen's share price to reach $36.08 in the next twelve months. This suggests that the stock has a possible downside of 1.1%. View Analyst Price Targets for Qiagen.

What is the consensus analysts' recommendation for Qiagen?

20 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Qiagen in the last year. There are currently 1 sell rating, 12 hold ratings and 7 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Qiagen.

Has Qiagen been receiving favorable news coverage?

News coverage about QGEN stock has been trending extremely negative recently, according to InfoTrie Sentiment Analysis. InfoTrie identifies positive and negative press coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Qiagen earned a news sentiment score of -4.2 on InfoTrie's scale. They also gave news articles about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the company's share price in the next several days. View News Stories for Qiagen.

Are investors shorting Qiagen?

Qiagen saw a decrease in short interest in the month of February. As of February 14th, there was short interest totalling 4,810,000 shares, a decrease of 10.6% from the January 30th total of 5,380,000 shares. Based on an average daily trading volume, of 2,990,000 shares, the days-to-cover ratio is currently 1.6 days. Currently, 2.3% of the company's stock are short sold. View Qiagen's Current Options Chain.

Who are some of Qiagen's key competitors?

What other stocks do shareholders of Qiagen own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Qiagen investors own include Gilead Sciences (GILD), Netflix (NFLX), NVIDIA (NVDA), Boeing (BA), Pfizer (PFE), Twitter (TWTR), Verizon Communications (VZ), Cisco Systems (CSCO), QUALCOMM (QCOM) and Alibaba Group (BABA).

Who are Qiagen's key executives?

Qiagen's management team includes the folowing people:
  • Mr. Peer Michael Schatz, CEO, MD & Member of Management Board (Age 53)
  • Dr. Roland Sackers, CFO, MD & Member of Management Board (Age 50)
  • Dr. Barthold Piening, Sr. VP & Head of Global Operations (Age 61)
  • Mr. John Gilardi, VP of Corp. Communications & Investor Relations
  • Mr. Jean-Pascal Viola, Head of Corp. Bus. Devel., Intellectual Property & Litigation and Sr. VP

Who are Qiagen's major shareholders?

Qiagen's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Massachusetts Financial Services Co. MA (5.60%), FIL Ltd (2.37%), Victory Capital Management Inc. (1.59%), Hardman Johnston Global Advisors LLC (1.11%), Aviva PLC (1.04%) and State Street Corp (0.96%).

Which institutional investors are selling Qiagen stock?

QGEN stock was sold by a variety of institutional investors in the last quarter, including AQR Capital Management LLC, Hardman Johnston Global Advisors LLC, FIL Ltd, Marshall Wace LLP, William Blair Investment Management LLC, Russell Investments Group Ltd., Martingale Asset Management L P and FMR LLC.

Which institutional investors are buying Qiagen stock?

QGEN stock was bought by a variety of institutional investors in the last quarter, including Victory Capital Management Inc., Farallon Capital Management LLC, Victory Capital Management Inc., DekaBank Deutsche Girozentrale, Platinum Investment Management Ltd., Twin Securities Inc., York Capital Management Global Advisors LLC and First Trust Advisors LP.

How do I buy shares of Qiagen?

Shares of QGEN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Qiagen's stock price today?

One share of QGEN stock can currently be purchased for approximately $36.47.

How big of a company is Qiagen?

Qiagen has a market capitalization of $8.22 billion and generates $1.53 billion in revenue each year. The company earns $-41,460,000.00 in net income (profit) each year or $1.43 on an earnings per share basis. Qiagen employs 4,952 workers across the globe.View Additional Information About Qiagen.

What is Qiagen's official website?

The official website for Qiagen is http://www.qiagen.com/.

How can I contact Qiagen?

Qiagen's mailing address is HULSTERWEG 82, VENLO P7, 5912 PL. The company can be reached via phone at 31-77-355-6600 or via email at [email protected]


MarketBeat Community Rating for Qiagen (NYSE QGEN)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  200 (Vote Outperform)
Underperform Votes:  241 (Vote Underperform)
Total Votes:  441
MarketBeat's community ratings are surveys of what our community members think about Qiagen and other stocks. Vote "Outperform" if you believe QGEN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe QGEN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/28/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel